Palisade Bio (PALI) Other Accumulated Expenses (2012 - 2026)

Palisade Bio (PALI) has reported Other Accumulated Expenses for 15 consecutive years, with $219000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $219000.0; the TTM figure through Mar 2026 stood at $219000.0 (changed N/A YoY), while the FY2025 annual figure was $433000.0, up 448.1% from the prior year.
• Other Accumulated Expenses eased to $219000.0 in Q1 2026 per PALI's latest filing, from $433000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $433000.0 in Q4 2025 and bottomed at $11000.0 in Q2 2022.
• Historically, Other Accumulated Expenses has averaged $174833.3 across 5 years, with a median of $184500.0 in 2023.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses plunged 86.25% — and 2024, when it jumped 1354.17%.
• Palisade Bio's Other Accumulated Expenses stood at $11000.0 in 2022, then surged by 1336.36% to $158000.0 in 2023, then slumped by 50.0% to $79000.0 in 2024, then jumped by 448.1% to $433000.0 in 2025, then slumped by 49.42% to $219000.0 in 2026.
• Business Quant data shows PALI's Other Accumulated Expenses at $219000.0 in Q1 2026, $433000.0 in Q4 2025, and $211000.0 in Q3 2025.